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Impact of incidental renal artery stenosis on
long-term mortality in patients with peripheral
arterial disease undergoing vascular procedure
Kwok-Wai Mui, MD,a Clark J. Zeebregts, MD, PhD,b Huib van den Hout, MD,c
Jef G. van Baal, MD, PhD,d Gerjan Navis, MD, PhD,a and Arend Jan-Woittiez, MD, PhD,e Groningen
and Almelo, The Netherlands
Objective: In peripheral arterial disease (PAD), mortality is high. Incidental renal artery stenosis (RAS) is a predictor of
mortality in PAD patients undergoing angiography. This might be relevant for risk-benefit assessment when vascular
surgery is considered, both in terms of perioperative risk, and in terms of life expectancy.
Methods: We studied the prognostic impact of incidental RAS in 488 subjects (334 men, 154 women; mean follow-up
6.0  3.4 years) who underwent angiography for PAD in a single center between 1997 and 2000. Renal arteries were
visualized and follow-up data concerning vascular procedures were analyzed.
Results: RAS (diameter reduction >50%) was present in 26%. Forty-six percent of study patients underwent a vascular
procedure (85% vascular surgery, remainder underwent amputation). Patients that underwent vascular surgery had a
better renal function at baseline, less history of stroke, and a larger proportion of smokers. Overall mortality was similar
for patients that underwent surgery (54.5%) and those without surgery (49.6%). There was no difference in 90-day
postoperative mortality for patients without or with RAS (7.2% vs 10.3%; NS). For subjects that underwent bypass
surgery, long-term mortality was substantially and significantly higher among those with RAS (65.1%) vs those without
RAS (43.5%). On Cox regression analysis, age was the only independent predictor of 90-day postoperative mortality. The
well-known cardiovascular risk factors of age, diabetes mellitus, history of prior peripheral vascular disease, smoking,
prior myocardial infarction, prior stroke, and amputation, as well as presence of RAS, were independent predictors for
overall mortality.
Conclusion: In PAD, incidental RAS predicts long-term mortality independent of other risk factors. The elevated
mortality is not due to a higher postoperative risk. Subjects presenting with PAD and RAS can therefore undergo vascular
procedures with the same risk as other patients. ( J Vasc Surg 2011;54:785-90.)
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tIn patients with peripheral arterial disease (PAD), mor-
tality is high1-3 and is most likely related to the clustering of
cardiovascular risk factors in these patients. When renal
function impairment is simultaneously present, mortality is
even higher.4 Renal artery stenosis (RAS) is frequently
encountered as an incidental finding in patients undergoing
routine angiography for PAD, with prevalence between 5%
and 40%.5-7We have previously demonstrated that inciden-
tal RAS is an independent predictor of a substantially
elevated mortality in PAD patients.6 The hypothesis is that
patients with incidental RAS have a higher mortality due to
higher postoperative risk. This might be relevant for risk-
benefit assessment when vascular surgery is considered,
both in terms of perioperative risk, and in terms of life
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doi:10.1016/j.jvs.2011.03.251xpectancy. Therefore, we investigated the prognostic im-
act of incidental RAS for long-term mortality as well as
erioperative mortality in a cohort of consecutive subjects
ho underwent intra-arterial digital subtraction angiogra-
hy (DSA) for PAD in a single center between 1997 and
000, and were treated either conservatively or by vascular
ntervention, depending on clinical assessment.
ETHODS
Design of the study. For the cohort6 of 550 con-
ecutive patients described previously, with clinically
onfirmed PAD by noninvasive examinations (ie, ankle-
rachial index or duplex ultrasound of the lower extremi-
ies), patient records were reviewed, and detailed additional
ata regarding vascular procedures were extracted. Briefly,
hese were subsequent patients, diagnosed between 1997
nd 2000. For the current study, follow-up formortality (in
he previous report until 2004) was extended until January
, 2008, amounting to a mean follow-up time of 6 years.
ll patients underwent angiography with the intention of
urgical or radiological intervention from January 1997 to
ecember 2000 in a single center, as judged by the vascular
urgeons. Patients in whom the angiography did not allow
roper assessment of the renal arteries were excluded from
he analysis. A single reviewer (H.H.), blinded to patients’
iagnoses and indications for the procedure, evaluated the
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September 2011786 Mui et alangiograms for the presence of renal artery stenosis. A
diameter reduction of 50% was considered diagnostic for
the presence of RAS; severe stenosis was considered to be
present when the stenosis exceeded 75%.8 Clinical data,
including surgical or radiological procedures, were ob-
tained from patient records and mortality data (until Janu-
ary 1, 2008) were obtained from the hospital information
system. The Institutional Review Board approved this
study.
Definitions. Hypertension was defined according to
the 2007 European Society of Hypertension-European
Society of Cardiology guidelines for the management of
arterial hypertension,9 prescription of antihypertensive
medications, or a clinical history of hypertension. A patient
was classified as having diabetes if there was a clinical history
of diabetes or if the patient was taking insulin or oral
antidiabetic agents. We used the abbreviated Modification
of Diet in Renal Disease (MDRD) equation advocated in
the Kidney Disease Outcomes Quality Initiative (KDOQI)
guidelines10 to estimate glomerular filtration rate (GFR).
Baseline characteristics. Eight clinical variables were
recorded at baseline (ie, time of angiography): the serum
creatinine before angiography; a history of myocardial in-
farction; a history of stroke; diabetes mellitus (present or
absent); smoking history (ever/stopped or never); history
of prior PAD (ie, previous treatment either conservative or
not otherwise specified); history of hypertension; and cur-
rent blood pressure at time of angiography.
Vascular procedures. Vascular procedures were de-
fined as either a surgical procedure (ie, primary vascular
bypass operation or amputation) or endovascular treatment
(ie, revascularization with primary percutaneous translumi-
nal angioplasty).
Statistical analysis. Comparisons between groups
(renal artery stenosis vs nonrenal artery stenosis) on base-
line variables were performed using Pearson 2 test. Sur-
vival was assessed by Kaplan-Meier curves, and to test for
independent predictors of mortality, multivariate analysis
was performed using single-step Cox regression analysis.
Table I. Baseline clinical characteristics of 488 patients wi
Characteristic
No operation
(n  264)
Age (years; mean  SD) 66.4  11.5
Male gender (% [n]) 63.3 (167)
Overall mortality (% [n]) 49.6 (131)
RAS (% [n]) 26.5 (70)
GFR (mL/min per 1.73 m2; mean  SD) 71.4  25.0
- GFR in patients with no RAS 76.0  23.6
- GFR in patients with RAS 58.4  24.1
History of hypertension (% [n]) 58.7 (155)
History of diabetes (% [n]) 29.5 (77)
History of myocardial infarction (% [n]) 20.8 (55)
History of stroke (% [n]) 20.1 (53)
History of smoking (% [n]) 57.5 (145)
History of previous PAD (% [n]) 31.4 (83)
GFR, Glomular filtration rate; PAD, peripheral arterial disease; RAS, renalThe renal function was classified according to the cut-offs becommended in the KDOQI criteria10 for defining mod-
rate (GFR 30-60 mL/min/1.73 m2) and severe (GFR
30 mL/min/1.73 m2) renal function impairment. All
tatistical analyses were performed in SPSS 14.0 for Win-
ows (SPSS, Chicago, Ill). Statistical significance was de-
ned as a P value .05.
ESULTS
From January 1997 to December 2000, 550 consecu-
ive angiograms were performed in patients, all with con-
rmed PAD. The renal arteries could be assessed in their
ntirety for renal artery stenosis (diameter reduction50%-
5% and 75%) in 499 angiograms. The reasons for in-
omplete visualization of the renal arteries were technical.
f the 499 evaluable patients, 11 patients could not be
ncluded because of incomplete clinical data. Atheroscle-
otic renal artery stenosis was present in 128 (26%) of the
88 patients; of these patients, 35 (27%) had a luminal renal
rtery stenosis of more than 75%, and 73 (57%) had a
ilateral renal artery stenosis.
Baseline characteristics of the population are presented
n Table I, by a break-up according to whether or not
urgery was performed. Of the 224 patients that underwent
vascular procedure, 190 (85%) had vascular surgery; the
emainder underwent an amputation. Patients that under-
ent vascular surgery had a better renal function at base-
ine, less history of stroke, and a larger proportion of
mokers, suggesting impact of patient selection for surgery.
ong-term mortality was similar for patients that under-
ent surgery (54.5%) and those without surgery (49.6%).
able II shows the baseline characteristics of patients who
nderwent percutaneous transluminal angioplasty (PTA)
ompared with vascular surgery. There was no difference in
hort-term mortality; only long-term mortality was slightly
levated in patients who underwent vascular surgery. There
as no difference in the renal function or the other risk
actors between the groups. Patients with RAS were older
nd had a higher prevalence of cardiovascular risk factors
Table III). In Table IV, mortality data are presented by a
d without vascular operation
Operation
(n  224) P
Odds ratio
(95% confidence interval)
65.7  11.2 .54
74.6 (167) .07
54.5 (122) .29 1.21 (0.85-1.74)
25.9 (58) .88 0.97 (0.65-1.45)
80.3  26.4 .0001
83.7  25.3 .003
70.6  27.4 .008
57.8 (129) .85 0.97 (0.67-1.39)
32.1 (72) .53 1.13 (0.77-1.67)
25.4 (57) .23 1.30 (0.85-1.98)
13.4 (30) .05 0.62 (0.38-1.003)
67.1 (147) .033 1.51 (1.03-2.20)
37.5 (84) .16 1.31 (0.90-1.90)
stenosis.th anreak-up by presence or absence of RAS, for patients that
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Volume 54, Number 3 Mui et al 787underwent surgery and those who had not. Among the
patients that underwent surgery, mortality was extremely
high for those with RAS and similar for those with or
without RAS that underwent amputation. For subjects that
underwent bypass surgery, mortality was substantially and
significantly higher among those with RAS (65.1%) versus
those without RAS (43.5%). There were no differences,
however, in 90-day and 1-year postoperative mortality for
patients with RAS as compared with no RAS, and there was
no difference in mortality between patients with unilateral
RAS versus bilateral RAS (Table V).
As shown by the Kaplan-Meier survival curves in the
Table II. Baseline clinical characteristics of 366 patients w
Characteristic
PTA
(n 142)
Age (years; mean  SD) 64.7  12.5
Male gender (% [n]) 61.3 (87)
Overall mortality (% [n]) 43.7 (62)
90-day postoperative mortality (% [n]) 4.2 (6)
1-year postoperative mortality (% [n]) 11.3 (16)
RAS (% [n]) 22.5 (32)
GFR (mL/min per 1.73 m2; mean  SD) 75.2  23.5
- GFR in patients with no RAS 78.5  22.7
- GFR in patients with RAS 63.6  22.8
History of hypertension (% [n]) 55.6 (79)
History of diabetes (% [n]) 27.1 (38)
History of myocardial infarction (% [n]) 20.4 (29)
History of stroke (% [n]) 14.1 (20)
History of smoking (% [n]) 64 (87)
History of previous PAD (% [n]) 28.2 (40)
GFR, Glomular filtration rate; PAD, peripheral arterial disease; PTA, percu
Table III. Baseline clinical characteristics of patients with
Characteristic No RAS (n  360)
Age (years; mean  SD) 64  11
Overall mortality (% [n]) 44.2 (159)
History of hypertension (% [n]) 53.8 (193)
History of diabetes (% [n]) 27.5 (98)
History of myocardial infarction (% [n]) 19.4 (70)
History of stroke (% [n]) 15.0 (54)
History of smoking (% [n]) 65.9 (228)
History of previous PAD (% [n]) 30.6 (110)
GFR (mL/min per 1.73 m2; mean  SD) 79.6  24.7
GFR, Glomular filtration rate; PAD, peripheral arterial disease; RAS, renal
Table IV. Long-term mortality and postoperative mortali
the presence or absence of renal artery stenosis
No R
No operation (n  264) 4.7
All operation (n  224) 48.2
- Bypass operation (n  190) 43.5
- Amputation (n  34) 84.2
90-day postoperative mortality (% [n]) 7
1-year postoperative mortality (% [n]) 13
RAS, Renal artery stenosis.Fig, the estimated 5- and 10-year survival probability for .atients who did not undergo a vascular procedure was 72%
nd 55%, respectively, for patients without RAS as com-
ared with 36% and 24%, respectively, for patients with
AS. The estimated 5- and 10-year survival probability for
atients with a vascular procedure in the group without
AS was 66% and 50%, respectively, versus 42% and 23%,
espectively, in the group with RAS (P  .0001).
The independent contribution of the various risk fac-
ors for 90-day postoperative mortality and long-termmor-
ality were assessed by Cox regression analysis, as shown in
able VI and VII, respectively. For the 90-day postopera-
ive mortality, age was the only independent predictor (P
nderwent PTA or vascular operation
Operation
(n  224) P
Odds ratio
(95% confidence interval)
65.7  11.2 .44
74.6 (167) .007
54.5 (122) .044 1.54 (1.01-2.36)
8.0 (18) .151 1.98 (0.77-5.12)
14.3 (32) .41 1.31 (0.69-2.49)
25.9 (58) .47 1.20 (0.73-1.97)
80.3  26.4 .06
83.7  25.3 .86
70.6  27.4 .22
57.8 (129) .68 1.09 (0.72-1.67)
32.1 (72) .31 1.27 (0.80-2.03)
25.4 (57) .27 1.33 (0.80-2.21)
13.4 (30) .85 0.94 (0.51-1.74)
67.1 (147) .54 1.15 (0.73-1.80)
37.5 (84) .066 1.53 (0.97-2.41)
s transluminal angioplasty; RAS, renal artery stenosis.
without renal artery stenosis
AS (n  128) P Odds ratio (95% confidence interval)
71  10 .0001
73.4 (94) .0001 3.50 (2.24-5.49)
71.1 (91) .001 2.12 (1.37-3.27)
39.8 (51) .009 1.75 (1.15-2.67)
32.8 (42) .002 2.02 (1.29-3.18)
22.7 (29) .048 1.66 (1.00-2.75)
51.2 (64) .004 0.54 (0.36-0.82)
44.5 (57) .004 1.83 (1.21-2.76)
3.9  26.2 .0001
stenosis.
r patients with or without vascular surgery according to
 360) RAS (n  128) P
/194) 74.3% (52/70) .0001
/166) 72.4% (42/58) .001
/147) 65.1% (28/43) .013
/19) 93.3% (14/15) .412
) 1.3 (6) .45
) 17.2 (10) .56ho uand
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September 2011788 Mui et albetes mellitus (DM), history of prior peripheral vascular
disease (PVD), smoking, prior myocardial infarction, prior
stroke, and amputation, as well as presence of RAS, were
independent predictors for long-term mortality.
DISCUSSION
In our previous study, we demonstrated that the mor-
tality in patients with PAD is extremely high, especially in
patients with concomitant incidental RAS and PAD. As
previously demonstrated, incidental RAS is an independent
predictor of long-term mortality in patients with PAD.6 In
this study, we have examined the contribution of the peri-
operative mortality on the total (5- and 10-year) mortality.
In contrast to our hypothesis or previous ideas,11 this
mortality was not influenced by the operative procedures,
irrespective of the patient had a RAS or not. The 90-day
and 1-year postoperative mortality was not significantly
different in patients with and without RAS. In terms of life
expectancy, patients with incidental RAS have higher mor-
tality in comparison to patients without RAS; however, this
is not due to postoperative short (90 days) or midterm (1
Table V. Long-term mortality and postoperative mortality
the presence of unilateral or bilateral renal artery stenosis
Unilater
No operation (n  70) 82.4
All operation (n  58) 71.4
- Bypass operation (n  43) 70.6
- Amputation (n  15) 75
90-days postoperative mortality (% [n]) 9
1-year postoperative mortality (% [n])
RAS, Renal artery stenosis.
Fig. Kaplan-Meier survival plots for patients with perip
outcome for those without renal artery stenosis (NRAS)year) mortality. PThe association between renal function and increased
ortality in patients with PAD undergoing lower extremity
ypass surgery has previously been described in this journal
y O’Hare et al12 and Owens et al.4 The first study found
hat patients receiving dialysis have a high incidence of
mputation within 1 year of lower extremity revasculariza-
ion that is not explained by a higher prevalence of demo-
raphic characteristics and comorbid conditions. The sec-
nd study demonstrated that in their cohort of 456
ubjects, patients with more severe renal insufficiency had
ignificantly higher mortality and lower amputation-free
urvival following lower extremity revascularization. The
etrimental effects of reduced renal function are profound
nd begin well before the onset of dialysis. The overall
-year survival in this cohort was 43%. This is comparable to
urs, namely 42% in patients with RAS after a vascular
rocedure. One may deduce from our data that the in-
reased mortality in the two above-mentioned studies is
ue to poor prognostic impact caused by incidental RAS. In
ontrast to the previously depicted studies, renal function
as not a prognostic marker for mortality in our cohort.
patients with or without vascular surgery according to
S (n  55) Bilateral RAS (n  73) P
8/34) 66.7% (24/36) .133
5/21) 73% (27/37) .90
2/17) 61.5% (16/26) .54
/4) 100% (11/11) .086
) 10.8 (4) .88
) 16.2 (6) .46
l arterial disease with and without surgery, comparing
with renal artery stenosis (RAS).for
al RA
% (2
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operated (Table I). The patients with PAD who did not
undergo vascular surgery had comparable kidney function
to those who underwent PTA (Table II). The question
arises how this is to be explained. One can hypothesize that
patients with the worst renal function had severe inoperable
vascular lesions and thus operation was deemed too risky.
In this respect, patients with RAS who went through am-
putation had the lowest estimated glomerular filtration rate
(eGFR; 60.2  18.2 mL/min/1.73 m2). Another expla-
nation may be preoperative selection bias by the initial
physicians who determined whether the patient should be
operated or not, based on renal function. Nevertheless, our
data give us insight in the combined occurrence of RAS and
renal function impairment as tools for preoperative risk-
benefit assessment. Despite the high mortality associated
with incidental RAS and renal insufficiency, they are not the
cause of short- or long-term postoperativemortality. It may
therefore be anticipated that all patients with surgical indi-
cation for vascular operation should be operated upon.
Some limitations of our study should be considered.
Table VI. Single-step Cox multivariate analysis of the
predictors of 90-day postoperative mortality
P
Hazard ratio
(95% confidence interval)
Age .001 1.09 (1.35-1.16)
History of hypertension .46 1.39 (0.58-3.31)
History of diabetes .72 1.18 (0.47-2.98)
History of myocardial infarction .23 1.68 (0.72-3.88)
History of stroke .43 1.50 (0.55-4.10)
History of smoking .11 2.23 (0.84-5.91)
History of previous peripheral
arterial disease .21 1.74 (0.74-4.13)
Amputation .31 1.79 (0.58-5.49)
PTA vs vascular bypass
operation .53 1.34 (0.50-3.83)
Glomerular filtration rate .72 0.99 (0.98-1.02)
Renal artery stenosis .93 1.04 (0.43-2.50)
PTA, Percutaneous transluminal angioplasty.
Table VII. Single-step Cox multivariate analysis of the
predictors of long-term mortality
P
Hazard ratio
(95% confidence interval)
Age .000 1.08 (1.06-1.10)
History of hypertension .418 1.12 (0.85-1.48)
History of diabetes .000 1.74 (1.31-2.30)
History of myocardial infarction .002 1.55 (1.67-2.06)
History of stroke .001 1.65 (1.22-2.25)
History of smoking .000 1.73 (1.28-2.33)
History of previous peripheral
arterial disease .003 1.50 (1.15-1.97)
Amputation .002 2.01 (1.29-3.12)
Glomerular filtration rate .553 1.00 (0.99-1.01)
Renal artery stenosis .024 1.39 (1.04-1.84)Because this was a retrospective post hoc analysis, all liabil-ties associated with the retrospective nature of the study
pply. The fact that 90-day postoperative mortality was not
ignificant may be due to underpowering of this study to
eally discriminate in short-term mortality. However, as
lready mentioned, the primary aim was to evaluate the
ong-term mortality in patients with PAD and incidental
AS. Regrettably, nonfatal perioperative events and medi-
ation use were not recorded. The medication use espe-
ially can be of importance, since the data of this study were
btained starting back in 1997. In the past, many patients
ith PAD were not treated as aggressively as today, such as
tandard with statins, angiotensin-converting enzyme in-
ibitors, or rigorous antiplatelet therapy. With the knowl-
dge of the medication use, it was possible to discriminate
hether the patients in our study were treated according to
he standards of current practice. Furthermore, we cannot
ule out that more favorable patients were selected for
urgery.
ONCLUSION
Incidental RAS predicts long-term mortality indepen-
ent of other risk factors. RAS is a strong marker of a poor
rognosis, manifested in increased mortality and inoper-
bility in patients with PAD. Consequently, risk assessment
n patients who undergo angiography should include visu-
lizing the renal arteries and measurement of renal func-
ion. Despite the elevated mortality in subjects with RAS,
he postoperative risk does not contribute to the amazing
igh total mortality, and therefore patients with PAD and
AS should not be withheld from vascular surgery.
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